Ecolab Ramps Up R&D And Ethics Record As Analysts Eye Upside
Ecolab (NYSE:ECL) has announced a significant US$500 million expansion of its R&D facilities in Minnesota, focusing on infection prevention and water treatment. This expansion, coupled with the company's 20th consecutive recognition as one of the World’s Most Ethical Companies, provides investors with insight into its strategic capital allocation and corporate governance. Analysts are forecasting double-digit annual earnings growth, with a consensus target price of US$321.57 per share, despite a flagged risk of high debt levels.
https://simplywall.st/stocks/us/materials/nyse-ecl/ecolab/news/ecolab-ramps-up-rd-and-ethics-record-as-analysts-eye-upside